Provided by Tiger Trade Technology Pte. Ltd.

CONSUN PHARMA

13.050
-0.210-1.58%
Volume:1.22M
Turnover:16.02M
Market Cap:10.94B
PE:8.86
High:13.400
Open:13.160
Low:13.020
Close:13.260
52wk High:18.420
52wk Low:11.967
Shares:838.00M
HK Float Shares:838.00M
Volume Ratio:0.75
T/O Rate:0.15%
Dividend:0.80
Dividend Rate:6.13%
EPS(LYR):1.473
ROE:24.40%
ROA:12.58%
PB:1.97
PE(LYR):8.86
PS:2.58

Loading ...

BRIEF-Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million

Reuters
·
May 27

CONSUN PHARMA Announces Share Buyback Initiative

Stock News
·
May 27

Consun Pharmaceutical Group Ltd - Share Repurchase Program up to HKD200 Mln

THOMSON REUTERS
·
May 27

Consun Pharmaceutical launches share buyback program of up to HKD 200 million

Reuters
·
May 27

Consun Pharmaceutical held AGM, shareholders approved HKD 0.4 final dividend for 2025

Reuters
·
May 26

Consun Pharma buys back 192,000 shares; treasury stock rises to 344,000

Bulletin Express
·
May 22

Consun Pharma repurchases 102,000 shares for HK$1.47 million; treasury stock rises to 152,000 shares

Bulletin Express
·
May 21

CONSUN PHARMA (01681) Executes Share Buyback, Spending HK$1.47 Million

Stock News
·
May 21

Consun Pharmaceutical files HKEX next-day return disclosing HKD 14.44 share buyback

Reuters
·
May 21

CONSUN PHARMA Repurchases Shares for HK$721,000 on May 20

Stock News
·
May 20

Consun Pharmaceutical files HKEX disclosure return, repurchases shares at HKD 14.42 each

Reuters
·
May 20

Concerns Surrounding Consun Pharmaceutical Group's (HKG:1681) Performance

Simply Wall St.
·
May 07

Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant

Bulletin Express
·
May 04

CONSUN PHARMA (01681) Undergoing Valuation Rerating as It Builds Leading "Nephrology Flagship" Competitive Edge

Stock News
·
May 03

Consun Pharmaceutical publishes 2025 ESG report

Reuters
·
Apr 28

CONSUN PHARMA’s 2025 ESG Report: Lower Emissions, Strong R&D Pipeline and RMB 14.76 Billion Brand Valuation

Bulletin Express
·
Apr 28

康臣藥業2025年度業績速覽:收入增長15.2%至34.17億元,腎科板塊領跑業務

Bulletin Express
·
Apr 28

Consun Pharma Schedules 26 May 2026 AGM, Proposes HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 28

ConSun Pharma Calls 26 May 2026 Hybrid AGM to Approve FY 2025 Results, HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 28

Consun Pharmaceutical announces annual general meeting

Reuters
·
Apr 28